XML 18 R45.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Options - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Mar. 31, 2019
Mar. 31, 2019
Sep. 30, 2019
Sep. 30, 2018
Mar. 31, 2018
Stock Options          
Weighted average grant date price per share     $ 11.88 $ 9.82  
Exercise of stock options to purchase shares of common stock (in shares)     32,325    
Proceeds from stock options exercised     $ 141,327    
Intrinsic value of options exercised     35,197    
Intrinsic value of options outstanding     196,086    
Intrinsic value of options exercisable     $ 4,597,593    
Weighted average remaining contractual term of options outstanding     8 years 2 months 5 days    
Weighted average remaining contractual term of options exercisable     8 years 11 days    
Stock based compensation expense for employee stock option awards     $ 2,539,294 $ 1,725,501  
Total unrecognized compensation cost     $ 8,854,490    
Stock based compensation expense, weighted average period     2 years 10 months 10 days    
Cumulative proceeds collected pursuant to the ESPP     $ 3,433    
Stock Options.          
Stock Options          
Remaining vesting period     4 years    
Stock Options. | Separation Agreement          
Stock Options          
Number of options outstanding in which vesting period was extended 127,576 127,576      
Vesting period extension   1 month      
Stock Options. | Separation Agreement | Former President and CFO          
Stock Options          
Acceleration of vesting     30,545    
Acceleration vesting period     6 months    
Remaining vesting period     12 months    
Additional stock option expense     $ 30,566    
Restricted Stock Units | 2016 Plan          
Stock Options          
Shares approved by board         127,576
Weighted average fair value (in dollars per share)     $ 10.78    
Remaining vesting period     4 years    
Restricted Stock Units | Separation Agreement | Former President and CFO          
Stock Options          
Vested during period (in shares) 2,658